AcelRx Pharmaceuticals, Inc. (ACRX) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1850 GATEWAY DRIVE SAN MATEO, CA 94404 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 20,770 | 51,630 | 42,886 | 66,137 | 105,715 | 60,469 | |||
| Cash and cash equivalents | 15,275 | 12,663 | 27,274 | 14,684 | 87,975 | 52,902 | |||
| Short-term investments | 495 | 38,967 | 15,612 | 51,453 | 17,740 | 7,567 | |||
| Other undisclosed cash, cash equivalents, and short-term investments | 5,000 | ||||||||
| Receivables | 309 | 160 | 635 | 520 | 401 | 1,533 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,178 | 1,111 | 1,626 | 3,295 | 854 | 956 | |||
| Inventory | 1,178 | 1,111 | 1,626 | 3,295 | 854 | 956 | |||
| Other undisclosed current assets | 2,309 | 2,588 | 1,683 | 1,736 | 1,024 | 455 | |||
| Total current assets: | 24,566 | 55,489 | 46,830 | 71,688 | 107,994 | 63,413 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 3,595 | 4,302 | 3,150 | 3,928 | ✕ | ✕ | |||
| Nontrade receivables | 263 | 351 | |||||||
| Property, plant and equipment | 10,261 | 15,928 | 15,659 | 14,552 | 11,483 | 11,051 | |||
| Intangible assets, net (including goodwill) | 8,819 | ||||||||
| Intangible assets, net (excluding goodwill) | 8,819 | ||||||||
| Restricted cash and investments | 178 | 178 | |||||||
| Other noncurrent assets | 246 | 2,174 | 656 | 925 | 527 | 207 | |||
| Deferred tax assets, net | ✕ | ✕ | ✕ | ✕ | ✕ | 703 | |||
| Total noncurrent assets: | 22,921 | 22,404 | 19,465 | 19,668 | 12,539 | 12,139 | |||
| TOTAL ASSETS: | 47,487 | 77,893 | 66,295 | 91,356 | 120,533 | 75,552 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 6,306 | 8,645 | 7,627 | 7,248 | 6,610 | 4,967 | |||
| Accounts payable | 2,040 | 2,121 | 2,737 | 1,720 | 2,070 | 1,424 | |||
| Accrued liabilities | 4,266 | 6,524 | 4,890 | 5,528 | 4,540 | 3,543 | |||
| Deferred revenue | 49 | 300 | ✕ | ✕ | |||||
| Debt | 5,763 | 8,796 | 8,735 | 5,600 | 8,611 | 7,727 | |||
| Disposal group, including discontinued operation | |||||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 362 | ||
| Other undisclosed current liabilities | 1,701 | 1,068 | 1,224 | 463 | 707 | 604 | |||
| Total current liabilities: | 13,770 | 18,509 | 17,635 | 13,611 | 15,928 | 13,660 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 8,757 | 15,746 | 24,157 | 3,380 | 11,369 | ||||
| Long-term debt, excluding current maturities | 5,007 | 13,140 | 20,517 | 3,380 | 11,369 | ||||
| Liabilities, other than long-term debt | 4,805 | 1,232 | 299 | 3,590 | 416 | 3,841 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 3,841 | ||
| Deferred revenue | 1,036 | 1,151 | 3,100 | ✕ | ✕ | ||||
| Deferred rent credit | 416 | ✕ | |||||||
| Other liabilities | 810 | 81 | 299 | 490 | |||||
| Operating lease, liability | 2,959 | 3,750 | 2,606 | 3,640 | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | 7,098 | 85,288 | 88,365 | 91,416 | 96,556 | 83,191 | |||
| Total noncurrent liabilities: | 11,903 | 95,277 | 104,410 | 119,163 | 100,352 | 98,401 | |||
| Total liabilities: | 25,673 | 113,786 | 122,045 | 132,774 | 116,280 | 112,061 | |||
| Equity | |||||||||
| Equity, attributable to parent | 21,814 | (35,893) | (55,750) | (41,418) | 4,253 | (36,509) | |||
| Common stock | 8 | 137 | 98 | 79 | 78 | 51 | |||
| Additional paid in capital | 447,635 | 437,554 | 382,637 | 356,609 | 349,194 | 261,310 | |||
| Accumulated deficit | (425,829) | (473,584) | (438,485) | (398,106) | (345,019) | (297,870) | |||
| Total equity: | 21,814 | (35,893) | (55,750) | (41,418) | 4,253 | (36,509) | |||
| TOTAL LIABILITIES AND EQUITY: | 47,487 | 77,893 | 66,295 | 91,356 | 120,533 | 75,552 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,771 | 2,818 | 5,416 | 2,289 | 2,151 | 7,995 | ||
| Sublease income | 199 | 598 | 596 | ✕ | ✕ | |||
| Cost of revenue | (2,591) | (4,275) | (6,032) | (6,806) | (3,976) | (369) | ||
| Cost of goods and services sold | (2,591) | (3,753) | (6,032) | (6,806) | (3,976) | (369) | ||
| Gross profit: | (820) | (1,457) | (616) | (4,517) | (1,825) | 7,626 | ||
| Operating expenses | (35,813) | (34,508) | (40,347) | (49,688) | (37,878) | (46,677) | ||
| Other undisclosed operating income | 3,976 | 369 | ||||||
| Operating loss: | (36,633) | (35,965) | (40,963) | (54,205) | (35,727) | (38,682) | ||
| Nonoperating income (expense) | 84,401 | 871 | 588 | 968 | (11,420) | (13,527) | ||
| Investment income, nonoperating | 366 | 124 | 583 | 2,166 | 1,138 | 510 | ||
| Interest and debt expense | (1,153) | (2,291) | (3,305) | (2,535) | (2,217) | (3,316) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | 46,615 | (37,385) | (43,680) | (55,772) | (49,364) | (55,525) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 1,153 | 2,291 | 3,305 | 2,535 | 2,217 | 3,316 | ||
| Income (loss) from continuing operations before income taxes: | 47,768 | (35,094) | (40,375) | (53,237) | (47,147) | (52,209) | ||
| Income tax expense (benefit) | (13) | (5) | (4) | (3) | (2) | 701 | ||
| Income (loss) from continuing operations: | 47,755 | (35,099) | (40,379) | (53,240) | (47,149) | (51,508) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (35,099) | (40,379) | (53,240) | (47,149) | (51,508) | |
| Net income (loss): | 47,755 | (35,099) | (40,379) | (53,240) | (47,149) | (51,508) | ||
| Other undisclosed net loss attributable to parent | ||||||||
| Net income (loss) attributable to parent: | 47,755 | (35,099) | (40,379) | (53,240) | (47,149) | (51,508) | ||
| Preferred stock dividends and other adjustments | (186) | |||||||
| Undistributed earnings (loss) allocated to participating securities, basic | (5,240) | |||||||
| Net income (loss) available to common stockholders, basic: | 42,329 | (35,099) | (40,379) | (53,240) | (47,149) | (51,508) | ||
| Other undisclosed net income available to common stockholders, diluted | 13 | |||||||
| Net income (loss) available to common stockholders, diluted: | 42,342 | (35,099) | (40,379) | (53,240) | (47,149) | (51,508) | ||
Comprehensive Income ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 47,755 | (35,099) | (40,379) | (53,240) | (47,149) | (51,508) | ||
| Comprehensive income (loss): | 47,755 | (35,099) | (40,379) | (53,240) | (47,149) | (51,508) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (3) | |||||||
| Comprehensive income (loss), net of tax, attributable to parent: | 47,755 | (35,099) | (40,379) | (53,240) | (47,149) | (51,511) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.